tiprankstipranks
Advertisement
Advertisement

NMRA Stock Latest News

Neumora Therapeutics price target lowered to $4 from $6 at Mizuho
The FlyNeumora Therapeutics price target lowered to $4 from $6 at Mizuho
22d ago
NMRA
Neumora Therapeutics price target lowered to $5 from $8 at Needham
PremiumThe Fly
Neumora Therapeutics price target lowered to $5 from $8 at Needham
24d ago
NMRA
Neumora Therapeutics price target lowered to $7 from $18 at H.C. Wainwright
PremiumThe Fly
Neumora Therapeutics price target lowered to $7 from $18 at H.C. Wainwright
24d ago
NMRA
Clear Street says Neumora failed trial does not impact LB Pharmaceuticals LB-102
PremiumThe Fly
Clear Street says Neumora failed trial does not impact LB Pharmaceuticals LB-102
25d ago
LBRX
NMRA
Neumora Ends Navacaprant After Phase 3 Trial Failure
PremiumCompany Announcements
Neumora Ends Navacaprant After Phase 3 Trial Failure
25d ago
8K
NMRA
Neumora Therapeutics announces KOASTAL studies miss primary endpoint
PremiumThe FlyNeumora Therapeutics announces KOASTAL studies miss primary endpoint
25d ago
NMRA
Neumora Shareholders Approve Directors, Auditor and Executive Pay
Premium
Company Announcements
Neumora Shareholders Approve Directors, Auditor and Executive Pay
1M ago
8K
NMRA
Analyst Reiterates Buy on Neumora, Maintaining $18 Price Target Ahead of Key KOASTAL-2/3 Depression Readouts
Premium
Ratings
Analyst Reiterates Buy on Neumora, Maintaining $18 Price Target Ahead of Key KOASTAL-2/3 Depression Readouts
1M ago
NMRA
Neumora’s NMRA-323511 Alzheimer’s Agitation Study Reaches Completion, Setting Up the Next Investor Catalyst
PremiumCompany Announcements
Neumora’s NMRA-323511 Alzheimer’s Agitation Study Reaches Completion, Setting Up the Next Investor Catalyst
2M ago
NMRA
Neumora Therapeutics Securities Lawsuit Enters New Procedural Phase as Plaintiffs Prepare New Complaint
PremiumClass Action
Neumora Therapeutics Securities Lawsuit Enters New Procedural Phase as Plaintiffs Prepare New Complaint
2M ago
NMRA
Ami Fadia Reiterates Buy on Neumora, Sees Compelling Risk-Reward Ahead of Phase 3 Readouts with Unchanged $8 Price Target
PremiumRatings
Ami Fadia Reiterates Buy on Neumora, Sees Compelling Risk-Reward Ahead of Phase 3 Readouts with Unchanged $8 Price Target
2M ago
NMRA
Analyst Initiates Buy on Neumora, Citing Compelling Risk/Reward Ahead of Key Navacaprant Readouts and Broader Pipeline Upside
PremiumRatings
Analyst Initiates Buy on Neumora, Citing Compelling Risk/Reward Ahead of Key Navacaprant Readouts and Broader Pipeline Upside
2M ago
NMRA
Neumora Therapeutics reports Q1 EPS (30c), consensus (31c)
PremiumThe FlyNeumora Therapeutics reports Q1 EPS (30c), consensus (31c)
2M ago
NMRA
Neumora: Deep Pipeline and Near‑Term Clinical Catalysts Support Attractive Risk‑Reward and Buy Rating
Premium
Ratings
Neumora: Deep Pipeline and Near‑Term Clinical Catalysts Support Attractive Risk‑Reward and Buy Rating
3M ago
NMRA
Neumora Therapeutics management to meet with Piper Sandler
Premium
The Fly
Neumora Therapeutics management to meet with Piper Sandler
3M ago
NMRA
Neumora Therapeutics Maps High-Stakes Catalyst Road Ahead
PremiumCompany Announcements
Neumora Therapeutics Maps High-Stakes Catalyst Road Ahead
3M ago
NMRA
Neumora Therapeutics Warns Nasdaq Delisting Risk Could Hit Liquidity, Share Price, and Capital Access
PremiumCompany Announcements
Neumora Therapeutics Warns Nasdaq Delisting Risk Could Hit Liquidity, Share Price, and Capital Access
3M ago
NMRA
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
PremiumThe Fly
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
3M ago
IQ
SR
Options Volatility and Implied Earnings Moves Today, March 30, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 30, 2026
3M ago
CBAT
DFDV
Neumora Therapeutics reports Q4 EPS (35c), consensus (33c)
PremiumThe FlyNeumora Therapeutics reports Q4 EPS (35c), consensus (33c)
3M ago
NMRA
NMRA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
NMRA Earnings this Week: How Will it Perform?
4M ago
NMRA
Neumora Therapeutics management to meet virtually with Needham
Premium
The Fly
Neumora Therapeutics management to meet virtually with Needham
4M ago
NMRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >